Among recipients with HIV, kidney transplantation from donors with HIV is noninferior to that from donors without HIV.
A multiomic analysis led by the IrsiCaixa AIDS Research Institute has uncovered genetic and immune mechanisms in some ...
Fostemsavir plus optimized background therapy was associated with improvements in immune biomarkers among HTE patients with MDR HIV infection.
Progress has been made in HIV care. However, that doesn’t mean you don’t need a detailed plan for taking care of an ...
The following is a summary of “Infectious disease events in people with HIV receiving kidney transplantation: Analysis of the ...
Some people infected with HIV are teeming with virus, but don’t get sick. Their resistive powers probably come from a mix of ...
Researchers assessed whether switching to protease inhibitor-based antiretroviral therapy mitigates or reverses weight gain in patients with HIV infection.
GlobalData on MSN2d
Gilead and MSD to advance once-weekly HIV treatment to Phase IIIThe companies have presented positive Phase II data during an oral session at IDWeek 2024, in Los Angeles, US.
Affordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has ...
Affordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has ...
On September 10, experts across disciplines, from infectious disease clinicians to regulators to representatives from the pharmaceutical industry, convened at the inaugural ImmunOptimize workshop in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback